Gerry Castillo
Technik-/Wissenschafts-/F&E-Leiter bei PharmaIN Corp.
Aktive Positionen von Gerry Castillo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Gerry Castillo
Ehemalige bekannte Positionen von Gerry Castillo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ProteoTech, Inc.
 ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Ausbildung von Gerry Castillo
| University of Toronto | Doctorate Degree |
| University of Saskatchewan | Undergraduate Degree |
| University of Windsor | Graduate Degree |
Statistik
International
| Kanada | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Health Technology |
ProteoTech, Inc.
ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Health Services |
- Börse
- Insiders
- Gerry Castillo
- Erfahrung
